Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,031 | 272 | 86.1% |
| Travel and Lodging | $449.74 | 1 | 9.6% |
| Education | $201.95 | 4 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $842.21 | 56 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $456.26 | 31 | $0 (2020) |
| Stryker Corporation | $449.74 | 1 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $388.22 | 23 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $378.89 | 25 | $0 (2021) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $370.43 | 25 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $351.98 | 32 | $0 (2020) |
| PFIZER INC. | $274.20 | 22 | $0 (2019) |
| Astellas Pharma US Inc | $227.16 | 6 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $185.52 | 12 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $449.74 | 1 | Stryker Corporation ($449.74) |
| 2021 | $18.11 | 1 | Janssen Pharmaceuticals, Inc ($18.11) |
| 2020 | $650.18 | 40 | Amgen Inc. ($190.35) |
| 2019 | $1,337 | 88 | Amgen Inc. ($303.57) |
| 2018 | $1,269 | 82 | Amgen Inc. ($316.15) |
| 2017 | $959.31 | 65 | Novartis Pharmaceuticals Corporation ($213.43) |
All Payment Transactions
277 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/26/2024 | Stryker Corporation | PRO (Device) | Travel and Lodging | Cash or cash equivalent | $449.74 | General |
| Category: TRAUMA & EXTREMITIES | ||||||
| 01/28/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/09/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $109.14 | General |
| Category: Cardiology | ||||||
| 11/03/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/27/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $4.47 | General |
| Category: Cardiology | ||||||
| 10/23/2020 | Abbott Laboratories | Mitra Clip system (Device) | Food and Beverage | In-kind items and services | $13.28 | General |
| Category: Vascular | ||||||
| 10/09/2020 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.13 | General |
| Category: Cardiovascular | ||||||
| 10/07/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Cardiovascular | ||||||
| 10/07/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $4.69 | General |
| Category: Cardiology | ||||||
| 09/18/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/02/2020 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/07/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $10.13 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/04/2020 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2020 | Amgen Inc. | Corlanor (Drug), Repatha | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Cardiology | ||||||
| 07/30/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/10/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/19/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/22/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/27/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/11/2020 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.56 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/09/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | PRADAXA (Drug), JARDIANCE, PRAXBIND | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/06/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/06/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/03/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Cardiology | ||||||
| 02/27/2020 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $13.02 | General |
| Category: STRUCTURAL HEART | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2020 | 40 | 3,659 | 4,364 | $693,924 | $214,131 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 621 | 969 | $264,335 | $81,148 | 30.7% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2020 | 484 | 487 | $90,977 | $28,172 | 31.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 136 | 239 | $44,145 | $14,107 | 32.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 115 | 117 | $41,362 | $13,231 | 32.0% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Facility | 2020 | 200 | 200 | $40,358 | $12,662 | 31.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 84 | 84 | $34,902 | $10,435 | 29.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 118 | 124 | $23,297 | $6,663 | 28.6% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Facility | 2020 | 197 | 198 | $20,379 | $6,245 | 30.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 24 | 24 | $12,420 | $3,999 | 32.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 29 | 40 | $10,634 | $3,433 | 32.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 231 | 244 | $10,465 | $3,218 | 30.7% |
| 93312 | Insertion of probe in esophagus for heart ultrasound examination including interpretation and report | Facility | 2020 | 32 | 33 | $9,267 | $2,993 | 32.3% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2020 | 240 | 241 | $9,141 | $2,818 | 30.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 330 | 375 | $5,570 | $2,629 | 47.2% |
| 93793 | Anti-clotting management for patient taking warfarin | Office | 2020 | 132 | 244 | $7,076 | $2,178 | 30.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 17 | 17 | $6,233 | $1,937 | 31.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 17 | 17 | $7,069 | $1,827 | 25.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 20 | 20 | $5,454 | $1,304 | 23.9% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2020 | 15 | 15 | $5,997 | $1,302 | 21.7% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 15 | 15 | $3,936 | $1,261 | 32.0% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2020 | 67 | 67 | $3,813 | $1,232 | 32.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 15 | 15 | $4,055 | $999.02 | 24.6% |
| 93350 | Ultrasound examination of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report | Facility | 2020 | 17 | 17 | $3,092 | $938.10 | 30.3% |
| 93978 | Ultrasound scan of vena cava or groin graft or vessel blood flow | Facility | 2020 | 26 | 26 | $2,677 | $869.51 | 32.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 13 | 14 | $2,501 | $838.59 | 33.5% |
About Dr. David Stroh, MD
Dr. David Stroh, MD is a Nuclear Cardiology healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144286212.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Stroh, MD has received a total of $4,683 in payments from pharmaceutical and medical device companies, with $449.74 received in 2024. These payments were reported across 277 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,031).
As a Medicare-enrolled provider, Stroh has provided services to 3,659 Medicare beneficiaries, totaling 4,364 services with total Medicare billing of $214,131. Data is available for 1 year (2020–2020), covering 42 distinct procedure/service records.
Practice Information
- Specialty Nuclear Cardiology
- Other Specialties Cardiovascular Disease
- Location Jacksonville, FL
- Active Since 04/26/2006
- Last Updated 04/01/2020
- Taxonomy Code 207UN0901X
- Entity Type Individual
- NPI Number 1144286212
Products in Payments
- ELIQUIS (Drug) $588.24
- Repatha (Biological) $515.70
- ENTRESTO (Drug) $456.26
- PRO (Device) $449.74
- XARELTO (Drug) $378.89
- LifeVest (Device) $370.43
- Corlanor (Drug) $326.51
- MULTAQ (Drug) $212.32
- PRALUENT (Drug) $175.90
- Mitra Clip system (Device) $158.65
- WATCHMAN (Device) $134.65
- PRADAXA (Drug) $133.76
- BRILINTA (Drug) $92.59
- LEXISCAN (Drug) $50.06
- FARXIGA (Drug) $42.84
- CHANTIX (Drug) $37.94
- PRALUENT ALIROCUMAB INJECTION (Biological) $35.00
- LOKELMA (Drug) $34.02
- NORTHERA (Drug) $30.97
- KENGREAL (Drug) $30.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.